[The technique of stereotactic I125 brachytherapy (permanent implants) of brain tumors in Vienna].
Methods of stereotactic target localisation are used in brachytherapy of brain tumors for many years. Since 1987 eight patients with inoperable astrocytomas grade I to III were treated at the Neurosurgical Clinic and Clinic for Radiotherapy of the University Vienna by permanent stereotactic I125-seed implantation. For that purpose a newly developed applicator was used. Preliminary results confine the low risk of operation, but the follow-up time is too short for evaluation of the treatment success. Principal problems of brain brachytherapy are discussed in the light of international data. In general, I125 brachytherapy is a useful and well tolerated way of treatment of low grade astrocytomas, the risk is low, which is especially important for children and old patients.
Hawliczek
R
R
Universitätsklinik für Strahlentherapie und Strahlenbiologie Wien, Osterreich.
Grunert
P
P
Ferraz-Leite
H
H
Alesch
F
F
D001254:Astrocytoma / Q000532:radiotherapy*; D001918:Brachytherapy / Q000295:instrumentation / Q000379:methods*; D001932:Brain Neoplasms / Q000532:radiotherapy*; D005909:Glioblastoma / Q000532:radiotherapy*; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage*; D013238:Stereotaxic Techniques
D007457:Iodine Radioisotopes
Technik der stereotaktischen J125-Brachytherapie (permanente Implantate) von Hirntumoren in Wien.